A detailed history of Driehaus Capital Management LLC transactions in Ideaya Biosciences, Inc. stock. As of the latest transaction made, Driehaus Capital Management LLC holds 437,123 shares of IDYA stock, worth $13.5 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares
437,123
Previous 437,123 -0.0%
Holding current value
$13.5 Million
Previous $15.3 Million -0.0%
% of portfolio
0.17%
Previous 0.17%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$34.37 - $43.46 $165,216 - $208,912
-4,807 Reduced 1.09%
437,123 $15.3 Million
Q1 2024

May 15, 2024

SELL
$34.2 - $47.13 $16.1 Million - $22.2 Million
-470,856 Reduced 51.58%
441,930 $19.4 Million
Q4 2023

Feb 14, 2024

BUY
$24.59 - $35.83 $5.29 Million - $7.72 Million
215,325 Added 30.87%
912,786 $32.5 Million
Q3 2023

Nov 14, 2023

BUY
$21.07 - $29.77 $9.17 Million - $13 Million
435,025 Added 165.76%
697,461 $18.8 Million
Q2 2023

Aug 14, 2023

BUY
$13.33 - $25.53 $3.5 Million - $6.7 Million
262,436 New
262,436 $6.17 Million
Q3 2020

Nov 16, 2020

SELL
$11.22 - $14.46 $1.19 Million - $1.53 Million
-106,009 Closed
0 $0
Q2 2020

Aug 14, 2020

SELL
$3.59 - $18.57 $244,385 - $1.26 Million
-68,074 Reduced 39.1%
106,009 $1.51 Million
Q2 2019

Aug 14, 2019

BUY
$9.58 - $11.95 $1.67 Million - $2.08 Million
174,083 New
174,083 $1.73 Million

Others Institutions Holding IDYA

About IDEAYA Biosciences, Inc.


  • Ticker IDYA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,067,700
  • Market Cap $1.48B
  • Description
  • IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company's lead product candidates include IDE397, a methionine adenosyltransferase 2a inhibitor that is in Phase I clinica...
More about IDYA
Track This Portfolio

Track Driehaus Capital Management LLC Portfolio

Follow Driehaus Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Driehaus Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Driehaus Capital Management LLC with notifications on news.